Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis

BACKGROUND. The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine‐based triplet and neurokinin‐1 receptor antagonists (NK‐1RAs)‐based triplet. However, which one shows better antiemetic effect remained unclear. MATERIALS AND METHODS...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Zhang, Zhonghan, Zhang, Yaxiong, Chen, Gang, Hong, Shaodong, Yang, Yunpeng, Fang, Wenfeng, Luo, Fan, Chen, Xi, Ma, Yuxiang, Zhao, Yuanyuan, Zhan, Jianhua, Xue, Cong, Hou, Xue, Zhou, Ting, Ma, Shuxiang, Gao, Fangfang, Huang, Yan, Chen, Likun, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Формат: Artigo
Язык:Inglês
Опубликовано: AlphaMed Press 2018
Предметы:
Symptom Management and Supportive Care
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947448/
https://ncbi.nlm.nih.gov/pubmed/29330211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0378
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы